Trial Profile
A phase IIa study of MYDICAR in end-stage renal disease patients undergoing surgery for arteriovenous fistula creation in preparation for haemodialysis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Aug 2014
Price :
$35
*
At a glance
- Drugs SERCA 2a gene therapy (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 19 Aug 2014 New trial record